Table 1 Baseline characteristics by preoperative SF quintiles.
|  | Overall | Preoperative SF levels (μg/L) | p-value | ||||
|---|---|---|---|---|---|---|---|
Quintile 1 (≤51.81) | Quintile 2 (51.81–110.10) | Quintile 3 (110.10–180.70) | Quintile 4 (180.70–307.90) | Quintile 5 (>307.90) | |||
n | 12,841 | 2569 | 2571 | 2567 | 2566 | 2568 | Â |
SF; μg/L | 142.10 (65.63–266.40) | 24.30 (14.31–37.23) | 81.17 (65.67–95.55) | 142.20 (126.10–159.40) | 232.15 (203.83–266.70) | 461.80 (369.42–673.20) | <0.001 |
log10 SF | 2.10 (0.49) | 1.34 (0.27) | 1.90 (0.09) | 2.15 (0.06) | 2.37 (0.07) | 2.72 (0.20) | <0.001 |
Demographics | |||||||
 Age; years | 70 (67–75) | 71 (67–75) | 70 (67–75) | 70 (67–74) | 70 (67–75) | 70 (67–74) | <0.001 |
 Male | 7903 (61.5%) | 1584 (61.7%) | 1346 (52.4%) | 1506 (58.7%) | 1649 (64.3%) | 1818 (70.8%) | <0.001 |
 BMI; kg/m2 | 24.12 (3.43) | 24.03 (3.52) | 24.09 (3.38) | 24.34 (3.40) | 24.33 (3.38) | 23.79 (3.43) | <0.001 |
Preexisting comorbidities | |||||||
 Renal insufficiency | 299 (2.3%) | 35 (1.4%) | 40 (1.6%) | 50 (1.9%) | 81 (3.2%) | 93 (3.6%) | <0.001 |
 Diabetes mellitus | 3152 (24.5%) | 669 (26.0%) | 634 (24.7%) | 604 (23.5%) | 574 (22.4%) | 671 (26.1%) | 0.006 |
 Cancer | 7659 (59.6%) | 1762 (68.6%) | 1546 (60.1%) | 1488 (58.0%) | 1425 (55.5%) | 1438 (56.0%) | <0.001 |
 Anemia | 3265 (25.4%) | 1397 (54.4%) | 418 (16.3%) | 310 (12.1%) | 406 (15.8%) | 734 (28.6%) | <0.001 |
Baseline laboratory examination | |||||||
 Hb; g/L | 126.00 (19.26) | 112.47 (20.03) | 127.91 (16.17) | 131.68 (15.67) | 131.52 (17.07) | 126.42 (20.13) | <0.001 |
 NLR | 2.07 (1.53–2.96) | 2.14 (1.59–3.05) | 1.97 (1.46–2.67) | 1.94 (1.47–2.68) | 2.03 (1.52–2.91) | 2.37 (1.70–3.65) | <0.001 |
 TBil; μmol/L | 15.82 (30.32) | 9.59 (7.26) | 11.13 (7.02) | 12.03 (9.49) | 13.71 (17.63) | 32.62 (61.11) | <0.001 |
 ALT; U/L | 20.76 (29.76) | 13.72 (13.35) | 15.46 (12.07) | 17.73 (21.15) | 20.49 (26.32) | 36.43 (51.32) | <0.001 |
Operation related variables | |||||||
 Emergency surgery | 399 (3.1%) | 60 (2.3%) | 48 (1.9%) | 72 (2.8%) | 74 (2.9%) | 145 (5.6%) | <0.001 |
 Surgery specialty |  |  |  |  |  |  | <0.001 |
 Obstetrics/Gynecology | 138 (1.1%) | 16 (0.6%) | 22 (0.9%) | 35 (1.4%) | 35 (1.4%) | 30 (1.2%) |  |
 Hepatobiliary/Pancreatic/Gastrointestinal | 7248 (56.4%) | 2109 (82.1%) | 1456 (56.6%) | 1267 (49.4%) | 1151 (44.9%) | 1265 (49.3%) |  |
 Orthopedic | 747 (5.8%) | 66 (2.6%) | 135 (5.3%) | 183 (7.1%) | 168 (6.5%) | 195 (7.6%) |  |
 Urology | 1185 (9.2%) | 102 (4.0%) | 211 (8.2%) | 276 (10.8%) | 303 (11.8%) | 293 (11.4%) |  |
 Thoracic | 891 (6.9%) | 67 (2.6%) | 179 (7.0%) | 230 (9.0%) | 236 (9.2%) | 179 (7.0%) |  |
 Vascular | 693 (5.4%) | 44 (1.7%) | 137 (5.3%) | 157 (6.1%) | 195 (7.6%) | 160 (6.2%) |  |
 Otorhinolaryngology—Head & Neck, Plastic, or Abdominal wall surgery | 1421 (11.1%) | 116 (4.5%) | 359 (14.0%) | 331 (12.9%) | 373 (14.5%) | 242 (9.4%) |  |
 Endoscopic | 518 (4.0%) | 49 (1.9%) | 72 (2.8%) | 88 (3.4%) | 105 (4.1%) | 204 (7.9%) |  |
 Surgery duration; hours | 2.50 (1.53–3.50) | 2.83 (2.00–3.67) | 2.33 (1.47–3.33) | 2.33 (1.45–3.33) | 2.25 (1.42–3.42) | 2.57 (1.45–3.75) | <0.001 |
Outcome | |||||||
 POD | 445 (3.5%) | 111 (4.3%) | 57 (2.2%) | 65 (2.5%) | 85 (3.3%) | 127 (4.9%) | <0.001 |